PureTech Health PLC PRTC's resTORbio Files IPO Registration Statement (3613Y)
December 05 2017 - 2:00AM
UK Regulatory
TIDMPRTC
RNS Number : 3613Y
PureTech Health PLC
05 December 2017
5 December 2017
THIS ANNOUNCEMENT IS NOT FOR RELEASE, PUBLICATION OR
DISTRIBUTION IN WHOLE OR IN PART IN OR INTO THE UNITED STATES OR
IN, INTO OR FROM ANY JURISDICTION WHERE TO DO SO WOULD CONSTITUTE A
VIOLATION OF THE RELEVANT LAWS OR REGULATIONS OF THAT
JURISDICTION.
PureTech Health plc
PureTech's resTORbio Files Confidential Submission of Draft
Registration Statement for Proposed Initial Public Offering
PureTech Health plc (LSE: PRTC), an advanced, clinical-stage
biopharmaceutical company, is pleased to note that resTORbio, Inc.,
an affiliate of PureTech Health, today announced that it has
previously confidentially submitted a draft registration statement
on Form S-1 with the United States Securities and Exchange
Commission relating to the proposed initial public offering of its
common stock. The announcement is being issued in accordance with
Rule 135 under the U.S. Securities Act of 1933, as amended.
The full text of the announcement from resTORbio is as
follows:
resTORbio Files Confidential Submission of Draft Registration
Statement for Proposed Initial Public Offering
Boston, Massachusetts, December 5, 2017 - resTORbio, Inc. today
announced that it has previously confidentially submitted a draft
registration statement on Form S-1 with the Securities and Exchange
Commission (the "SEC") relating to the proposed initial public
offering of its common stock. The number of shares to be offered
and the price range for the proposed offering have not yet been
determined. The initial public offering is expected to commence
after the SEC completes its review process, subject to market and
other conditions.
This press release does not constitute an offer to sell or the
solicitation of an offer to buy any securities. Any offers,
solicitations or offers to buy, or any sales of securities will be
made in accordance with the registration requirements of the
Securities Act of 1933, as amended ("Securities Act"). This
announcement is being issued in accordance with Rule 135 under the
Securities Act.
This announcement does not constitute, or form part of, any
offer or invitation to sell, allot or issue, or any solicitation of
any offer to purchase or subscribe for, any securities, nor shall
it (or any part of it) or the fact of its distribution form the
basis of, or be relied upon in connection with, or act as any
inducement to enter into, any contract or commitment for
securities.
Shareholders and potential investors should note this
announcement does not constitute a recommendation concerning the
proposed initial public offering by resTORbio (the "Offering"). The
price and value of securities and any income from them can go down
as well as up. Past performance is not a guide to future
performance. Information in this announcement or any of the
documents relating to the Offering cannot be relied upon as a guide
to future performance. There is no guarantee that the Offering will
occur and you should not base your financial decisions in relation
to the Offering at this stage. Potential investors should consult a
professional advisor as to the suitability of the Offering for the
entity or person concerned.
This announcement does not contain or constitute an offer of, or
solicitation of an offer to buy or subscribe for the securities
referred to herein to any person in any jurisdiction, including the
United States, Australia, Canada, Japan, New Zealand, or the
Republic of South Africa or in any jurisdiction to whom or in which
such offer or solicitation is unlawful.
This announcement contains inside information for the purposes
of Article 7 of Regulation (EU) 596/2014.
Contact:
PureTech Health FTI Consulting
Allison Mead Talbot Ben Atwell, Rob
+1 617 651 3156 Winder
amt@puretechhealth.com +44 (0) 20 3727
1000
This information is provided by RNS
The company news service from the London Stock Exchange
END
MSCUGGWWPUPMPPC
(END) Dow Jones Newswires
December 05, 2017 02:00 ET (07:00 GMT)
Puretech Health (LSE:PRTC)
Historical Stock Chart
From Jun 2024 to Jul 2024
Puretech Health (LSE:PRTC)
Historical Stock Chart
From Jul 2023 to Jul 2024